Loading…
BB Biotech invests in fast-growing biotechnology companies that are developing and marketi…
0.1%
% of portfolio
+17.6%
Net Return YTD
Performance, year to date.
BB Biotech AG
The chart below shows the share price for the actual year.
Data source: FactSet
This Map details Holdings of the Fund and their Scores.
Loading…
Data source: FactSet
Each pebble is an asset. It's color reflects the score; its size reflects the portfolio-weight.
Asset Name | Return YTD % (Asset curr.) | % of fund | |
|---|---|---|---|
| Ionis Pharmaceuticals, Inc. | +87.1% | 14.0% | |
| argenx SE | +2.9% | 13.6% | |
| Neurocrine Biosciences, Inc. | +2.8% | 8.5% | |
| Alnylam Pharmaceuticals, Inc | +93.8% | 6.9% | |
| Vertex Pharmaceuticals Incorporated | -2.7% | 6.2% | |
| Agios Pharmaceuticals, Inc. | +22.2% | 5.1% | |
| Incyte Corporation | +22.8% | 4.2% | |
| Scholar Rock Holding Corp. | -13.8% | 4.1% | |
| Akero Therapeutics, Inc. | +70.7% | 3.9% | |
| Avidity Biosciences Inc | +49.8% | 3.2% |
Contact our team to arrange for a call.